Abstract: This invention is directed to devices and methods for improving wound closures produced during endoscopic surgery. These methods are directed to delivering and applying a quantity of hemostatic agents in either powder, solid, liquid, or gel form onto an open wound produced e.g., by polyp removal, followed by the application of pressure. The method is implemented preferably using existing endoscopic equipment; however, modifications to existing endoscopic insertion tubes, application and tamping devices and endoscopic clips deployed from the distal end of the insertion tube during endoscopic surgery are also within the scope of this invention.

Abstract: This invention is directed to devices and methods for improving wound closures produced during endoscopic surgery. These methods are directed to delivering and applying a quantity of hemostatic agents in either powder, solid, liquid, or gel form onto an open wound produced e.g., by polyp removal, followed by the application of pressure. The method is implemented preferably using existing endoscopic equipment; however, modifications to existing endoscopic insertion tubes, application and tamping devices and endoscopic clips deployed from the distal end of the insertion tube during endoscopic surgery are also within the scope of this invention.

Abstract: This invention is directed to devices and methods for improving wound closures produced during endoscopic surgery. These methods are directed to delivering and applying a quantity of hemostatic agents in either powder, solid, liquid, or gel form onto an open wound produced e.g., by polyp removal, followed by the application of pressure. The method is implemented preferably using existing endoscopic equipment; however, modifications to existing endoscopic insertion tubes, application and tamping devices and endoscopic clips deployed from the distal end of the insertion tube during endoscopic surgery are also within the scope of this invention.

Abstract: An apparatus for total intravenous anesthesia includes at least one supply and infusion pump for an intravenous anesthesia agent carried by the apparatus housing, and at least one monitor for monitoring the characteristics of the patient during the total intravenous anesthesia. The at least one intravenous anesthesia agent preferably includes a first intravenous anesthesia agent, and more preferably, an analgesic, having a relatively quick offset so that the effects wears off relatively quickly upon stopping intravenous infusion. For monitoring the patient, the apparatus preferably includes at least one of an electrocardiogram, a blood oxygen monitor, a blood carbon dioxide monitor, inspiration/expiration oxygen, inspiration/expiration carbon dioxide, a blood pressure monitor, a pulse rate monitor, a respiration rate monitor, and a patient temperature monitor, for example. The first intravenous anesthesia agent may be an esterase metabolized opioid, such as remifentanil.

Abstract: A portable care facility includes at least one container defining a generally box-shaped configuration in a closed condition. The container is sized for transport and shipping and is constructed and arranged to be openable and expandable from the box-shaped configuration into a larger, operative configuration defining a space sufficient to conduct certain procedures therein. Tenting structure is provided in the container and is sized and configured to be supported over the space to define a ceiling over the space and to extend in at least one direction generally outwardly from the space to define a covered triage area.